The Leadership Team at Oxford BioMedica is responsible for setting the strategic direction and vision of the company, overseeing the development and commercialization of innovative cell and gene therapies. This diverse group of executives collaborates on scientific, operational, financial, and human resource strategies to drive growth and ensure the successful execution of projects while maintaining the highest standards of quality and compliance in all aspects of the business.
Amy Barker
Principal Scientist
Aude Cazenave
Vice President Head Of Manufac...
Ceri Schofield
Vice President, Head Of Qualit...
Diane Varley
Principal Scientist
Frank Mathias
CEO
Joshua Hughes
Principal Scientist
Kyriacos Mitrophanou...
Chief Scientific Officer
Lisa James
Chief People Officer
Nicholas Clarkson
Vice President, Head Of Proces...
Sébastien Ribault
Chief Commercial Officer
View all